90848313 - SIERRA ONCOLOGY

Information

• Trademark
• 90848313

• Source

• Serial Number

  90848313

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  July 26, 2021
  3 years ago

• Transaction Date

  March 04, 2024
  9 months ago

• Status Date

  March 04, 2024
  9 months ago

• Published for Opposition Date

  December 06, 2022
  2 years ago

• Location Date

  January 31, 2023
  a year ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  VERHOSEK, WILLIAM T

• Attorney Docket Number

  84210946

  Attorney Name

  Christopher M. Hanes

  Law Office Assigned Location Code

  M50

• Owners

  • SIERRA ONCOLOGY, INC

Case File Statements

• GS0051: Biological and chemical preparations for the treatment of cancer; pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and disorders; pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical reagents; medical diagnostic reagents, assays, and test kits for testing of body fluids; cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use but specifically excluding biological eye tissue, corneas, and other ocular or eye-related human tissue intended for subsequent tissue and organ implantation; pharmaceutical preparations for use in the prevention and treatment of dermatology, oncology, hematology and for gastroenterological disorders but specifically excluding biological eye tissue, corneas, and other ocular or eye-related human tissue intended for subsequent tissue and organ implantation
• GS0441: Medical services; medical services for the treatment of cancer; medical analysis services for the diagnosis and treatment of patients and persons; medical analysis services for the diagnosis of cancer; providing cancer screening services; providing a website via a global computer network featuring information in the fields of health and health information regarding cancer, cancer treatment, recovery and survival; medical evaluation and diagnosis of cancer; medical analysis for cancer diagnosis and prognosis based on DNA and RNA screening; medical services for the diagnosis of conditions of the human body; providing a website via a global computer network featuring information regarding the medical diagnosis and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing a website via a global computer network featuring information regarding the medical diagnosis and treatment of dermatology, oncology, hematology, and for gastroenterological disorders; providing medical information, consultancy and advisory services; providing links to the websites of others featuring information about the diagnosis and treatment of cancer
• D10000: "ONCOLOGY"
• GS0421: Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical drug development services; research relating to medicines; medical research; pharmaceutical research and development services; medical research services in the field of cancer; research and development of biological and chemical preparations for the treatment of blood diseases, bone and bone marrow diseases, and cancer; research and development of pharmaceutical products, preparations and compounds for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development of pharmaceutical preparations for use in dermatology, oncology, hematology, and for gastroenterological disorders; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials regarding pharmaceutical preparations and drugs in the field of blood diseases, and cancers; DNA screening and analysis services for scientific research purposes

Case File Event Statements

• 3/4/2024 - 9 months ago

  24 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 3/4/2024 - 9 months ago

  23 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 8/2/2023 - a year ago

  22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/31/2023 - a year ago

  21 - SOU EXTENSION 1 GRANTED Type: EX1G

• 7/31/2023 - a year ago

  20 - SOU EXTENSION 1 FILED Type: EXT1

• 7/31/2023 - a year ago

  19 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/8/2023 - a year ago

  18 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 1/31/2023 - a year ago

  17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 12/6/2022 - 2 years ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/6/2022 - 2 years ago

  15 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/16/2022 - 2 years ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/31/2022 - 2 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/21/2022 - 2 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/20/2022 - 2 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/20/2022 - 2 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/12/2022 - 2 years ago

  9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/12/2022 - 2 years ago

  8 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 10/12/2022 - 2 years ago

  7 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 4/21/2022 - 2 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/21/2022 - 2 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 4/21/2022 - 2 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/20/2022 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 9/24/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/29/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP